Search

Dolan Auto Group donates a much-appreciated coffee break to thank healthcare heroes on the front lines Renown Health employees enjoyed a free drink on Monday made possible by the generous team at Dolan Auto Group. Starbucks beverages were made available to Renown staff throughout the day at Renown Regional Medical Center, giving these dedicated care givers a chance to take a break, relax and refuel for the busy days ahead. “We recognize the incredible challenges these past few weeks have had on our staff as we prepare to treat patients with COVID-19 symptoms in the coming weeks and months. As demonstrated by the outpouring of public appreciation, the heroism and courage of our caregivers has captivated our entire community,” said Dr. Tony Slonim, president and CEO of Renown Health. “It’s extremely powerful to see our community partners recognize their efforts by giving back to our heroes on the front lines. Acts of kindness like the Dolan family showed us today, help to fuel our team to continue fighting the good fight against COVID-19.” The Dolan coffee break was open to all Renown employees today, including healthcare providers, administration, security officers, lab technicians, environmental services, facilities and all employees. Employees enjoyed a Starbucks drink of their choice as they headed to their patient care units or ended their shifts. Many employees were overcome with emotion after reading the sticker displayed on the Starbucks cup. The Dolan family’s message to Renown employees read, “You are our hero. We are keeping you in our thoughts and prayers. Thank you for all you do.” “This was our way of taking care of the dedicated staff members at Renown and extending our sincere thanks for their tremendous efforts,” said Brady Dolan, dealer principal and chief operations officer at Dolan Auto Group. “We hope they were able to enjoy a sense of normalcy during these uncertain times and find comfort knowing that our community is deeply grateful for their commitment and dedication, now more than ever.” From Personal Protective Equipment and hot meals, financial donations and hand-written cards and messages, Renown has received an influx of community donations amid the COVID-19 pandemic. Every donation makes a difference and has the power to brighten a staff member’s day and support their patient care mission. Those interested in supporting Renown’s healthcare heroes are invited to visit www.renowne.org/give for more ways on how to help. For up-to-date information on Renown’s approach to keeping our community safe, visit our website at www.renown.org/covid-19/.     About Dolan Auto Group: Dolan Auto Group – offering northern Nevada’s finest selection of new cars – as well as the largest inventory of pre-owned vehicles in Reno, Sparks, Carson City and now Fernley. As one of the leading families of automotive dealerships in the state, Dolan Auto Group has been family-owned and-operated for nearly four decades, consisting of Dolan Mazda, Dolan Kia, Dolan Lexus, Dolan Dodge RAM, Dolan Fernley Chrysler Jeep Dodge RAM and Dolan Toyota, northern Nevada’s largest volume Toyota dealer. Learn more at DolanAutoGroup.com About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving northern Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown has a long tradition and commitment to continually improve the care and the health of our community. For more information, visit renown.org.

Read More About Renown Health Heroes Received Received A Free Starbucks Drink

Gilead Sciences, Inc. (Nasdaq: GILD) and the Renown Institute for Health Innovation (IHI) today announced a strategic collaboration to collect and analyze genetic and electronic health data that can enhance the understanding of nonalcoholic steatohepatitis (NASH) and potentially inform development of treatment options for the disease. Under the terms of the collaboration and license agreement, Gilead will provide funding to Renown IHI to sequence and analyze the DNA of 15,000 individuals living with NASH or nonalcoholic fatty liver disease (NAFLD) as well as a control cohort of 40,000 individuals in Nevada. “Combining the sequencing of protein coding DNA, with extensive electronic health record data will enable a deep analysis of the roles of genetics and environment in NASH incidence and progression,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “The analysis of these large datasets in collaboration with Renown IHI could help identify genetic variants that impact the risk of developing NASH and thereby advance the discovery and development of new treatments for this disease.” Renown Health is Nevada’s most comprehensive and integrated healthcare network and maintains electronic health records for 1.02 million registered patients. In 2016, Renown Health and the Desert Research Institute established the Healthy Nevada Project (HNP), the nation’s first community-based population health study. In 2017 HNP began a partnership with Helix to leverage its population health services, Exome+™ sequencing, and consumer engagement tools. The HNP is now an ongoing collaboration between Renown IHI, the Desert Research Institute, a global leader in environmental data and applied research, and Helix, a personal genomics company. HNP combines genetic, environmental, social and clinical data to address individual and community health needs with the goal of improving health across the state and the nation. The HNP currently has 40,000 participants. “Combining genetic sequencing with large sets of data can play a critical role in understanding and identifying serious health risks, including diseases like NASH. We are excited to collaborate with Gilead to better understand the condition and its complexities,” said Anthony Slonim, MD., DrPH. “Any genetic variants identified in participants through the collaboration may be shared with the participants for patient care purposes.”     About NASH Nonalcoholic steatohepatitis (NASH) is a chronic form of liver disease characterized by excess fat in the liver, inflammation, and liver cell damage. Inflammation and liver cell damage can cause scarring of the liver, or fibrosis, and ultimately lead to cirrhosis or liver cancer. NASH is more common in people with certain conditions, including obesity and type 2 diabetes. There are currently limited approved treatments for patients living with NASH.   About Gilead Sciences Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.   About Renown Health Renown Health is a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. Renown is one of the region’s largest private employers with a workforce of more than 7,000. It comprises three acute care hospitals, a rehabilitation hospital, the area’s most comprehensive medical group and urgent care network, and the region’s largest and only locally owned not-for-profit insurance company, Hometown Health. Renown Health’s commitment has extended beyond traditional health care to include community health and well-being. Renown Health works to improve health care through science, research and genetics; forge community partnerships that improve lives and develop innovative models that are improving health care in Nevada. For more information, visit renown.org.    About Helix Helix’s mission is to empower every person to improve their life through DNA. Helix is accelerating the integration of genomic data into clinical care and broadening the impact of large-scale population health programs by providing comprehensive expertise in DNA sequencing, bioinformatics, and individual engagement. Powered by their proprietary Exome+™ assay—a panel-grade exome enhanced by more than 300,000 informative non-coding regions—Helix offers health systems a scalable solution which enables the discovery of medically relevant, potentially life-saving, genetic information. Additionally, Helix offers a suite of DNA-powered products for continued individual engagement and discovery. Helix is headquartered in the San Francisco Bay Area and has one of the world’s largest CLIA-certified, CAP-accredited Next Generation Sequencing labs, located in San Diego, California. Learn more at www.helix.com. Helix, the Helix logo, and Exome+ are trademarks of Helix Opco, LLC.   Gilead Forward-Looking Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks, uncertainties and other factors, including the risk that the parties may not realize the potential benefits of this collaboration, and Gilead may fail to discover, develop and commercialize any product candidates for the treatment of NASH. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These risks, uncertainties and other factors could cause actual results to differ materially from those referred to in the forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. These and other risks are described in detail in Gilead’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019, as filed with the U.S. Securities and Exchange Commission. All forward-looking statements are based on information currently available to Gilead, and Gilead assumes no obligation to update any such forward-looking statements. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.   Additional Media Contact: Sung Lee, Investors                                                                                                                                                        650-524-7792 Arran Attridge, Media                                                                                                                                                        650-425-8975

Read More About Gilead Sciences and Renown Institute for Health Innovation Announce Strategic Collaboration to Advance Understanding of Nonalcoholic Steatohepatitis (NASH)

Healthy Nevada Project’s community-based approach reveals up to 90% of CDC Tier 1 genetic condition risks missed using clinical care guidelines. In a new study published today in the journal Nature Medicine, researchers behind the Healthy Nevada Project® suggest that community-based genetic screening has the potential to efficiently identify individuals who may be at increased risk for three common inherited genetic conditions known to cause several forms of cancer and increased risk for heart disease or stroke. In 2018, the Healthy Nevada Project® (the largest, community-based population health study combining genetic, clinical, environmental and social data) started notifying consenting study participants who have certain genetic variants which predispose them to the Centers for Disease Control and Prevention (CDC) Tier 1 genetic conditions. The study focused on identifying carriers of these conditions, which include Hereditary Breast and Ovarian Cancer, Lynch Syndrome, and Familial Hypercholesterolemia, because they are the most common conditions and early detection and treatment could significantly lower morbidity and mortality. Initial results from almost 27,000 study participants showed that 90% of carriers of the CDC Tier 1 genetic conditions were not previously identified in a clinical setting. The authors conclude that population genetic screening would identify at-risk carriers not identified during routine care. “Our first goal was to deliver actionable health data back to the participants of the study and understand whether or not broad population screening of CDC Tier 1 genomic conditions was a practical tool to identify at-risk individuals,” explained Joseph Grzymski, Ph.D., the principal investigator of the Healthy Nevada Project®, a research professor at the Desert Research Institute (DRI), chief scientific officer for Renown Health and lead author of the study. “Now, two years into doing that, it is clear that the clinical guidelines for detecting risk in individuals are too narrow and miss too many at risk individuals.” Within the group of 26,906 Healthy Nevada Project® participants that Grzymski’s research team studied, 358 (1.33%) were carriers for CDC Tier 1 conditions. However, only 25% of those individuals met clinical guidelines for genetic screening. Additionally, more than 20% of the carriers already had a diagnosis of disease relevant to their underlying genetic condition. “We’re at a point now where it’s possible to do clinical-grade genetic screening at population-scale,” added James Lu, M.D. Ph.D., co-founder and chief scientific officer of Helix and senior co-author of the study. “What this study demonstrates is the potential impact of doing so. By making genetic screening available more broadly, we can help the millions of Americans who are unaware that they are living at increased risk for highly actionable, genetic conditions take action.” Most notably, the study found that of the 273 participants who were carriers of the CDC Tier 1 genetic conditions and had clinical record information, only 22 individuals showed any previous suspicion of their underlying genetic conditions. “For the first time, we are providing information at the individual level so study participants can make lifesaving changes to reduce their risk based on their genetics,” said Anthony Slonim, M.D., Dr.PH., FACHE, president and CEO of Renown Health and co-director of the Project® study. “We’re conducting research on the community level to develop leading-edge research on health determinants for entire neighborhoods, states and eventually, the country. Returning these results allows us to understand the prevalence of genetically programmed diseases and illnesses that we have here in Nevada and ensure we are providing the best prevention and care plans. For the individual, the return of results can be life changing.” According to the CDC, early detection and intervention of the Tier 1 genetic conditions could have a meaningful potential for clinical action ability and a positive impact on public health. The Healthy Nevada Project®, which launched in 2016, offers free genetic testing to every Nevadan, aged 18 and older, interested in learning more about their health and genetic profile. With more than 50,000 study participants enrolled in four years, the Healthy Nevada Project® has become the fastest-enrolling genetic study in the world. For more about the Healthy Nevada Project® please visit healthynv.org     Renown Institute for Health Innovation is a collaboration between Renown Health – a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute – a recognized world leader in investigating the effects of natural and human induced environmental change and advancing technologies aimed at assessing a changing planet. Renown IHI research teams are focused on integrating personal healthcare and environmental data with socioeconomic determinants to help Nevada address some of its most complex environmental health problems; while simultaneously expanding the state’s access to leading-edge clinical trials and fostering new connections with biotechnology and pharmaceutical companies. Learn more at Healthynv.org. Helix is the leading population genomics company operating at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+Ⓡ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research. In response to the COVID-19 public health crisis, Helix has launched a sensitive and scalable end-to-end COVID-19 test system to meet the needs of health systems, employers, governments, and other organizations across the country. Learn more at www.helix.com.

Read More About Population Genetic Screening Show to Efficiently Identify Increased Risk for Inherited Disease

Donors, Orvis School of Nursing at University of Nevada, Reno and Renown Health create history by awarding tuition assistance to 29 nursing students and creating a future academic and career pipeline. The University of Nevada, Reno has officially begun its yearlong sesquicentennial celebration (October 2023 and through October 2024). Today, a celebration was held as donors, Renown Health and the University of Nevada, Reno Orvis School of Nursing awarded 29 nursing students with tuition support as part of the Gerald “Jerry” Smith Academic-Practice Partnership established with the Renown Health Foundation. The Practice Partnership is named in honor of the late Jerry Smith of the Nell J. Redfield Foundation and supported by a generous lead gift from the Redfield Foundation and Stephanie Kruse, owner of KPS3 and chair of the Renown Health Foundation Board as they work to create a sustainable nursing workforce in northern Nevada for years to come. Kruse made a generous planned gift to the Renown Health Foundation and the Renown Nursing Excellence Endowment Fund. This was the lead gift for the endowment, after a significant cash gift to the Nursing Education Fund last summer. Kruse of Reno was recently awarded the prestigious 2023 Trustee of the Year Award from the Nevada Hospital Association for her exceptional leadership; professional excellence; outstanding achievements; innovative accomplishments and extraordinary compassion in caring for the community. The Gerald “Jerry” Smith Academic-Practice Partnership recipients receive funding for tuition, books, and nursing fees, along with a guaranteed career in nursing with Renown Health following graduation and license obtainment. Eligible University of Nevada, Reno Orvis School of Nursing students, Nevada residents and those committed to working at Renown for at least three years post-graduation who are interested in applying for the tuition support can find the application in Canvas, University of Nevada’s learning management system. “Despite steady growth in the number of new nursing graduates from Nevada nursing programs and registered nurses moving to Nevada from other states, our state is in need of additional registered nurses simply to meet the increased population growth and demand,” noted Brian Erling, MD, MBA, President & CEO of Renown Health. “The daughter of a nurse and a former nurse herself, Stephanie understands the importance of attracting and retaining nurses within our healthcare systems. Stephanie has made a significant and lasting contribution by helping to train and grow the next generation of nurses and we so appreciate her service, and her many contributions to Renown and our community.” "Since our University first welcomed students to classes in 1874, the institution has been a place where dreams can be realized for the good of all. We are incredibly grateful for the Gerald ‘Jerry’ Smith Nursing Academic-Practice Partnership,” Brian Sandoval, President, University of Nevada, Reno (UNR) said. “The tuition support not only impact the lives and dreams of the nursing students being honored today, but positively influences the overall health of our community by ensuring that excellent healthcare professionals stay right here in northern Nevada.” “Jerry Smith had a strong belief in community collaboration, and we are beyond proud that this partnership is named in his memory. He would be thrilled to see the impact these gifts are having on these nursing students today,” said Greg Walaitis, Chief Development Officer for Renown Health Foundation. “Stepanie Kruse works tirelessly to improve access to better health and human services, and she is now encouraging others to join the fight by donating to the Gerald “Jerry” Smith Academic-Practice Partnership fund at Renown to help fund additional tuition assistance and support nurse education for our state. Her goal is to be able to provide full support to each of the 192 students in the Orvis School of Nursing program each year.” According to a white paper published by the Nevada Health Workforce Research Center (the Center) in December 2022, analysis by the Center revealed persistent, widespread health professional shortages in Nevada. Despite steady growth in the number of new nursing graduates from Nevada nursing programs and registered nurses moving to Nevada from other states, the Center estimated that Nevada currently needs over four thousand additional registered nurses simply to meet the national population-to-RN average. The partnership allows the Orvis School of Nursing to expand its graduating classes by 8 additional students a year. “At Renown, we take pride in placing an emphasis on education and career development. Partnering with the Orvis School of Nursing to create an academic pipeline is imperative for addressing the nursing shortage in Nevada,” said Melodie Osborn, Chief Nurse Executive at Renown Health. “Renown Health and the Orvis School of Nursing’s collaboration has been longstanding, and accomplishing this milestone reaffirms our partnership and our long legacy that both organizations have to nursing and education.” In addition to announcing the Practice Partnership, the Orvis School of Nursing has merged the traditional Bachelor of Science in Nursing program with the Accelerated Bachelor of Science in Nursing program. This merger has expanded the traditional Bachelor of Science in Nursing program from 72 students to 96 students admitted twice per year. The Bachelor of Science in Nursing program now admits a total of 192 students in the program each year. “We are excited to be accepting our first class of Gerald “Jerry” Smith Academic-Practice Partnership nursing students and to be increasing the number of nursing students who can enroll in the Orvis School of Nursing’s BSN program,” said Cameron G. Duncan, Interim Dean of the Orvis School of Nursing. “It’s integral for nursing students to get hands-on experience in an environment that places an emphasis on quality and excellence, which is why we’re proud to collaborate with Renown Health. We are so appreciative of Stephanie and the generous donors who will make education possible for students who might otherwise not be able to pursue a career in nursing.” Founded in 1864, Washoe County Hospital (which later became Renown Health) was the first hospital to open after Nevada became a state and is now the state’s largest not-for-profit healthcare organization and #1 hospital in Nevada (US News & World Report). Founded in 1956, the Orvis School of Nursing (OSN) is the oldest school of nursing in the state and committed to serving the healthcare needs of the people of Nevada through excellence in teaching, research, and service. In 2021, Renown Health affiliated with the University of Nevada Reno, School of Medicine creating the state’s first integrated health system. About Renown Health Renown Health is the region’s largest, locally governed, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California. With a diverse workforce of more than 7,000 associates, Renown has fostered a longstanding culture of excellence, determination, and innovation. The organization comprises a trauma center, two acute care hospitals, a children’s hospital, a rehabilitation hospital, a medical group and urgent care network, and the region’s largest, locally owned not-for-profit insurance company, Hometown Health. Renown is currently hiring great physicians, nurses and associates for careers in service; apply at renown.org/careers and volunteers to assist patients and their families at renown.org/about/volunteers. About University of Nevada, Reno The University of Nevada, Reno, is a public research university that is committed to the promise of a future powered by knowledge. Nevada’s land-grant university founded in 1874, the University serves 21,000 students. The University is a comprehensive, doctoral university, classified as an R1 institution with very high research activity by the Carnegie Classification of Institutions of Higher Education. Additionally, it has attained the prestigious “Carnegie Engaged” classification, reflecting its student and institutional impact on civic engagement and service, fostered by extensive community and statewide collaborations. More than $800 million in advanced labs, residence halls and facilities has been invested on campus since 2009. It is home to the University of Nevada, Reno School of Medicine, and Wolf Pack Athletics, maintains a statewide outreach mission and presence through programs such as the University of Nevada, Reno Extension, Nevada Bureau of Mines and Geology, Small Business Development Center, Nevada Seismological Laboratory, and is part of the Nevada System of Higher Education. Through a commitment to world-improving research, student success and outreach benefiting the communities and businesses of Nevada, the University has impact across the state and around the world. For more information, visit unr.edu.

Read More About Celebrating More Than 150 Years of Nursing, First Nevada Hospital and Nursing School Award First Jerry Smith Student Tuition Support